Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Samira Malekmohammadi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Adolfo Iulianelli

    Institute of Membrane Technology of the National Research Council (CNR-ITM), Via P. Bucci 17C, 87036 Rende, Italy

    1 shared publication
  • Amin Sabzi

    Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz 5166653431, Iran

    1 shared publication
  • Amir Zarebkohan

    Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

    1 shared publication
  • Elham Mashayekh

    Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115, Iran

    1 shared publication
  • Hajar Maleki

    Department of Chemistry, Institute of Inorganic and Materials Chemistry, University of Cologne, 50939 Cologne, Germany

    1 shared publication
  • Iman Bhia

    Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 1985717443, Iran

    1 shared publication

Latest Publications

  • Open Access

    Machine Learning–Driven Surrogate Modeling and Operating-Point Selection for a Microfluidic Diffusion-Membrane Platform for Transdermal Drug Delivery

    by Tara Torabi, Mahsa Jafar Harasy, Jafar Tahmoresnezhad, Samira Malekmohammadi, Adolfo Iulianelli, Kamran Ghasemzadeh

    Microfluidic diffusion systems provide a powerful in vitro platform for evaluating transdermal drug delivery (TDD), yet their predictive capability is often constrained by limited experimental datasets and nonlinear transport behavior across membrane—device configurations. This study integrates machine learning (ML) with microfluidic experimentation to develop accurate and generalizable surrogate models for cumulative drug permeation under different hydrodynamic and membrane conditions. This work presents an ML-augmented microfluidic TDD framework for predicting cumulative drug permeation from small experimental datasets. Caffeine cream permeation was examined across twelve device—membrane configurations (sMDC, mMDC, and LiveBox2 paired with PET, CA, rat skin, and alginate) at three perfusion flow rates. For each configuration, SVR, MLP, RFR, GBR, XGB, and KNN models were trained and cross-validated using only 33 experimental measurements. SVR showed the strongest overall performance among the evaluated models, achieving test R2 values typically above 0.97 and RMSE values of 2, accurately capturing the nonlinear time-flow-cumulative mass behavior of TDD profiles. A domain-bounded Gaussian-noise augmentation strategy was used to increase local sampling density while keeping augmented values within the experimentally observed time and cumulative-mass ranges. Polynomial equations were obtained from the predictions of SVR to capture the interaction between inputs and outputs. The trained SVR surrogates were then used for automated steady-state identification and surrogate-based operating-point selection, revealing the dependence of the selected flow rate on membrane permeability and device geometry. Alginate consistently delivered the highest steady-state cumulative mass across all systems (up to ~448 µg/cm2), establishing it as the most efficient TDD membrane among those evaluated. Finally, compact third-degree polynomial equations were derived from the SVR predictions, enabling explicit analytical prediction and rapid design-space exploration. Overall, these ML-derived models and analytical equations provide a fast, low-cost tool for predictive design, enabling rapid microfluidic system evaluation and operating-condition selection, and significantly accelerating the development and screening of next-generation TDD platforms.


  • Open Access

    Metal–Organic Frameworks for Cisplatin Delivery to Cancer Cells: A Molecular Dynamics Simulation

    by Elham Mashayekh, Zahra Nouri Khajeh Ghiasi, Iman Bhia, Zohreh Arefi Khorrami, Omid Malekahmadi, Mohammed Bhia, Samira Malekmohammadi, Yavuz Nuri Ertas

    Metal-organic frameworks (MOFs) are utilized as nanocarriers to enhance the efficiency of chemotherapy drugs, including cisplatin, which exhibit limitations such as side effects and resistance mechanisms. To evaluate the role of MOFs, we employed a molecular dynamics simulation, which, unlike other experiments, is cost-effective, less dangerous, and provides accurate results. Furthermore, we conducted molecular docking simulations to understand the interaction between cisplatin and MOF, as well as their internal interactions and how they bind to each other. Cisplatin and MOF molecules were parametrized using the Avogadro software and x2top command in GROMACS 5.1.2 and optimized by CP2K software; the Charmm-GUI site parametrized the cell cancer membrane. Three molecular dynamics simulations were conducted in four stages at various pHs, followed by simulated umbrella sampling. The simulations analyzed the pH responsiveness, total energy, Gibbs free energy, gyration radius, radial distribution function (RDF), solvent accessible surface area, and nanoparticles' toxicity. Results demonstrated that a neutral pH level (7.4) has greater adsorption and interaction compared to acidic pH values (6.4 and 5.4) because it displays the highest total energy (-17.1 kJ/mol), the highest RDF value (6.66), and the shortest distance (0.51 nm). Furthermore, the combination of cisplatin and MOFs displayed increased penetration compared to that of their individual forms. This study highlights the suitability of MOFs as nanocarriers and identifies the optimal pH values for desirable outcomes. Thus, it provides future studies with appropriate data to conduct their experiments in assessing MOFs.


  • Open Access

    Smart and Biomimetic 3D and 4D Printed Composite Hydrogels: Opportunities for Different Biomedical Applications

    by Samira Malekmohammadi, Negar Sedghi Aminabad, Amin Sabzi, Amir Zarebkohan, Mehdi Razavi, Massoud Vosough, Mahdi Bodaghi, Hajar Maleki

    In recent years, smart/stimuli-responsive hydrogels have drawn tremendous attention for their varied applications, mainly in the biomedical field. These hydrogels are derived from different natural and synthetic polymers but are also composite with various organic and nano-organic fillers. The basic functions of smart hydrogels rely on their ability to change behavior; functions include mechanical, swelling, shaping, hydrophilicity, and bioactivity in response to external stimuli such as temperature, pH, magnetic field, electromagnetic radiation, and biological molecules. Depending on the final applications, smart hydrogels can be processed in different geometries and modalities to meet the complicated situations in biological media, namely, injectable hydrogels (following the sol-gel transition), colloidal nano and microgels, and three dimensional (3D) printed gel constructs. In recent decades smart hydrogels have opened a new horizon for scientists to fabricate biomimetic customized biomaterials for tissue engineering, cancer therapy, wound dressing, soft robotic actuators, and controlled release of bioactive substances/drugs. Remarkably, 4D bioprinting, a newly emerged technology/concept, aims to rationally design 3D patterned biological matrices from synthesized hydrogel-based inks with the ability to change structure under stimuli. This technology has enlarged the applicability of engineered smart hydrogels and hydrogel composites in biomedical fields. This paper aims to review stimuli-responsive hydrogels according to the kinds of external changes and t recent applications in biomedical and 4D bioprinting.